The platinum compounds, cis-platinum (IV) diamminotetrachloride, and cis-platinum (II) diamminodichloride, have been reported to be active in inhibiting and regressing small solid Sarcoma 180 tumors and Leukemia L1210 tumors in mice. They were also active in successfully regressing large (Day 8) solid Sarcoma 180 tumors in 63 to 100% of the animals, with no apparent irreversible damage to the host, in a number of dose schedules.

1

This work was supported by Research Grant GM-10890 of the National Institute of General Medical Science and Research Grant CA-11349 of the National Cancer Institute.

This content is only available via PDF.
©1970 American Association for Cancer Research.
1970
Cancer Research, Inc.